Bryan Hancock

Bryan Hancock has extensive experience in various research and scientific roles at companies like Fate Therapeutics Inc, InhibRx, and Vaxiion Therapeutics. With a background in Biochemistry and Molecular Biology, Bryan has worked on developing cancer immunotherapies and monoclonal antibody therapeutics. Through their work, Bryan has demonstrated expertise in assay development, project integration, and fostering innovation in the field of molecular biology.